TCL Archive NCI Considering Proposal To Form “Drug Discovery Cooperative Groups”; Concept To DCT Board In June February 26, 1982
TCL Archive NCI funds four radiation oncology cancer disparities research partnerships. October 10, 2003
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive Black Men Face Disparate Cancer Burden; Minority Rates Vary, Klausner Tells House April 3, 1998